BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 11876702)

  • 1. Helicobacter pylori and dyspepsia: physicians' attitudes, clinical practice, and prescribing habits.
    O'Connor HJ
    Aliment Pharmacol Ther; 2002 Mar; 16(3):487-96. PubMed ID: 11876702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are dyspepsia management guidelines coherent with primary care practice?
    Cardin F; Zorzi M; Furlanetto A; Guerra C; Bandini F; Polito D; Bano F; Grion AM; Toffanin R
    Scand J Gastroenterol; 2002 Nov; 37(11):1269-75. PubMed ID: 12465724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helicobacter pylori and non-malignant diseases.
    Rokkas T; Simsek I; Ladas S
    Helicobacter; 2007 Oct; 12 Suppl 1():20-2. PubMed ID: 17727456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reappraisal of non-invasive management strategies for uninvestigated dyspepsia: a cost-minimization analysis.
    Ladabaum U; Chey WD; Scheiman JM; Fendrick AM
    Aliment Pharmacol Ther; 2002 Aug; 16(8):1491-501. PubMed ID: 12182749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of the NIH Consensus Conference on Helicobacter pylori on physician prescribing among a Medicaid population.
    Thamer M; Ray NF; Henderson SC; Rinehart CS; Sherman CR; Ferguson JH
    Med Care; 1998 May; 36(5):646-60. PubMed ID: 9596056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helicobacter pylori management: how to improve the therapeutic confusion in practice.
    Talley NJ
    Can J Gastroenterol; 2003 Jun; 17 Suppl B():21B-24B. PubMed ID: 12905978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The appropriate use of proton pump inhibitors (PPIs): Need for a reappraisal.
    Savarino V; Dulbecco P; de Bortoli N; Ottonello A; Savarino E
    Eur J Intern Med; 2017 Jan; 37():19-24. PubMed ID: 27784575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Good bugs and bad bugs: indications and therapies for Helicobacter pylori eradication.
    Kuipers EJ; Janssen MJ; de Boer WA
    Curr Opin Pharmacol; 2003 Oct; 3(5):480-5. PubMed ID: 14559092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helicobacter pylori and Nonmalignant Diseases.
    Potamitis GS; Axon AT
    Helicobacter; 2015 Sep; 20 Suppl 1():26-9. PubMed ID: 26372821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of Helicobacter pylori eradication rate in patients with non-ulcer dyspepsia and peptic ulcer diseases according to proton pump inhibitors].
    Hong EJ; Park DI; Oh SJ; Song MJ; Choi WH; Hong CH; Park JH; Kim HJ; Cho YK; Shon CI; Jeon WK; Kim BI
    Korean J Gastroenterol; 2008 Aug; 52(2):80-5. PubMed ID: 19077498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helicobacter pylori eradication therapy: a discrepancy between current guidelines and clinical practice.
    Lee JM; Deasy E; O'Morain CA
    Eur J Gastroenterol Hepatol; 2000 Apr; 12(4):433-7. PubMed ID: 10783997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helicobacter pylori and upper gastrointestinal disease: a survey of gastroenterologists in the United Kingdom.
    Milne R; Logan RP; Harwood D; Misiewicz JJ; Forman D
    Gut; 1995 Sep; 37(3):314-8. PubMed ID: 7590423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The management of Helicobacter pylori infection in primary care: a systematic review of the literature.
    Childs S; Roberts A; Meineche-Schmidt V; de Wit N; Rubin G
    Fam Pract; 2000 Aug; 17 Suppl 2():S6-11. PubMed ID: 10960429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report.
    Malfertheiner P; Mégraud F; O'Morain C; Hungin AP; Jones R; Axon A; Graham DY; Tytgat G;
    Aliment Pharmacol Ther; 2002 Feb; 16(2):167-80. PubMed ID: 11860399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eradication of Helicobacter pylori.
    O'Connor HJ
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S113-9. PubMed ID: 7735927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of a Helicobacter pylori treatment strategy on health care expenditures in patients with peptic ulcer disease and dyspepsia.
    Kearney DJ; Liu CF; Crump C; Brousal A
    Am J Gastroenterol; 2003 Sep; 98(9):1952-62. PubMed ID: 14499771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Helicobacter pylori infection. Indications and regimens: an update.
    Bazzoli F; Bianchi Porro G; Bianchi MG; Molteni M; Pazzato P; Zagari RM
    Dig Liver Dis; 2002 Jan; 34(1):70-83. PubMed ID: 11926576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes research in Helicobacter pylori infection.
    Fendrick AM
    Aliment Pharmacol Ther; 1997 Apr; 11 Suppl 1():95-101. PubMed ID: 9146795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.
    Chung SJ; Lee DH; Kim N; Jung SH; Kim JW; Hwang JH; Park YS; Lee KH; Jung HC; Song IS
    Hepatogastroenterology; 2007 Jun; 54(76):1293-6. PubMed ID: 17629092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indications for treatment of Helicobacter pylori infection: a systematic overview.
    Veldhuyzen van Zanten SJ; Sherman PM
    CMAJ; 1994 Jan; 150(2):189-98. PubMed ID: 8287341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.